@entity572 ( @entity572 ) is the most effective treatment for advanced or end-stage @entity570 . However, @entity1211 ( @entity1211 ) remains one of its unresolved complications. We reviewed the records of 322 @entity1 undergoing primary @entity572 and investigated the efficacy of anticoagulant prophylaxis for @entity1211 . Our study cohort consisted of 60 @entity1 who received no anticoagulants, 100 @entity1 who received a factor Xa inhibitor (fondaparinux), 100 @entity1 who received low molecular weight heparin ( @entity2120 ), and 62 @entity1 who selectively received no anticoagulant prophylaxis due to perioperative @entity548 , weight, and/or hemoglobin concentration. Enhanced 64-slice multidetector row computed tomography was performed postoperatively for 7 days in all cases. The incidence of @entity1211 in the four groups was 15%, 9.0%, 6.0%, and 6.4%, respectively. The incidence of @entity1211 was significantly lower in the groups receiving anticoagulant prophylaxis and the group selectively receiving no anticoagulant prophylaxis than in the group receiving no anticoagulants. Complications of fondaparinux therapy included @entity409 in 4 cases (4.0%), minor @entity548 in 2 cases (2.0%), persistent wound drainage in 3 cases (3.0%), and eruption in 1 case (1.0%). The complications of @entity2120 therapy were persistent wound drainage in 1 case (1.0%) and progression of @entity417 in 1 case (1.0%). The incidence of @entity1211 was low in @entity1 who selectively received no anticoagulant prophylaxis, so we conclude that anticoagulant prophylaxis should be used selectively in @entity572 cases.

XXXX after total hip arthroplasty diagnosed by enhanced computed tomography:comparison of selective thromboprophylaxis and no thromboprophylaxis.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity417 :: ('MESH:D000740', 'Disease') :: ['anemia'] @entity548 :: ('MESH:D006470', 'Disease') :: ['bleeding'] @entity409 :: ('MESH:D008107', 'Disease') :: ['hepatic dysfunction'] @entity572 :: ('MESH:D006617', 'Disease') :: ['THA', 'Total hip arthroplasty'] @entity1211 :: ('MESH:D054556', 'Disease') :: ['VTE', 'venous thromboembolism'] @entity2120 :: ('MESH:D017984', 'Chemical') :: ['enoxaparin'] @entity570 :: ('MESH:D015207', 'Disease') :: ['hip osteoarthritis']
@entity1211 :: (MESH:D054556,Disease) :: ['Venous thromboembolism']
